FANCD2 and Fanconi’s Anemia

Slides:



Advertisements
Similar presentations
~2 lectures ~25 slides. Maybe 3 hr to prepare. Done Monday and to Charley… Other example of treatment and DNA damage & spindle checkpoints.
Advertisements

Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
The Mre11 complex is required for ATM activation and the G 2 /M checkpoint Carson, C.T. et al The EMBO J (Vol. 22), 2003.
Jordan A. Mays. Key Points: 8 XP family proteins repair DNA damaged by sunlight through Nucleotide Excision Repair. XPF-ERCC1 complex is a structure-specific.
Repair of DNA and XP Errol C. Friedberg (2003) DNA damage and repair. Nature 421:
A signal transducer and cancer Neurofibromin, ras, and cancer - utah.
Fanconi Anemia & FANCD2
FANCD2 FANCONI ANEMIA PROTEIN COMPLEMENTATION GROUP D2 by Meredith Binkley.
BRCA2 Blue: Rad51; Green: BRCA2
ATM, Ataxia Telangiectasia, & Cancer
Retinoic Acid Receptor Alpha and Acute Promyelocytic Leukemia Nidhi Thapar April 1, 2004.
Ataxia Telangiectasia (AT) By Brandy Chapman. Characteristics of Ataxia- telangiectasia: Progressive neuronal degeneration Loss of cerebellar function.
XPF Nucleotide Excision Repair. Xerderma Pigmentosum (XP) UV Light Sensitivity Early Age Freckling Severe Sunburning Keratosis Neurological defects Non-melonoma.
BRCA1 The First Breast Cancer Gene Presentation By Liz Mosley.
Ataxia- telangiectasia Mutated (ATM) Brooke Register.
Cancer Cell cycle, oncogenes and tumour suppressors Jake Turner.
Understanding Cancer Accelerated Biology. Faces of Cancer  You are a doctor interviewing a person (the piece of paper you got on the way in) with cancer.
Cyclins G1 cyclin (cyclin D) S-phase cyclins (cyclins E and A) mitotic cyclins (cyclins B and A) Cyclin-dependent kinases (Cdks)kinases G1 Cdk (Cdk4) S-phase.
Sigma-aldrich.com/cellsignaling Hypothetical Model on the Functions of the WRN, BLM and MRE11.
Bloom’s Syndrome and Bloom helicase Alexandra Otto March 16, 2004.
Definition of Xeroderma Pigmentosum: XP XP, first described in 1874, is a rare genetic defect in the nucleotide excision repair mechanism. It is characterized.
What is sickle cell disease? Sickle cell disease is a disorder that affects.
BRCA1: Tumor Suppression and Breast Cancer A breast cancer cell dividing.
Cancer When cell division goes wrong……. Growing out of control, cancer cells produce malignant tumors Cancer is a general term for many diseases in.
Breast Cancer and BRCA2. 1 million women worldwide diagnosed. 1 out of 12 women in Western Europe and the United States 30% mortality rate Highest cause.
Javad Jamshidi Fasa University of Medical Sciences, December 2015 Cancer Genetics Session 4 Medical Genetics.
FANCD2 & the Fanconi Anemia Tumor Suppressor Pathway Shayna Purcell Joo et al., 333 (6040):
Normal cell cycle DNA replication Doughter cells G2 phase Nuclear division Cytokinesis 1x.
Tumor Suppressors Versus Oncogenes. Retinoblastoma is a Cancerous Disease Hereditary childhood cancer: bilateral tumors in 25-30% of cases unilateral.
Natasha Adlakha Bio445. Discovery in Breast Cancer Reverse Genetics BReast CAncer Gene Chromosome 13 Tumor suppressor gene Penetrance Familial,
Tumor Suppressor Gene Involved in Breast and Ovarian Cancers SCIENCE96/gene.cgi?BRCA1.
Fanconi Anemia Anthony Winchell. What is Fanconi Anemia?
Thalassemia Ms. Hoge Jane Doe. What is Thalassemia Blood disorder that is inherited, in which the body makes an abnormal form of hemoglobin. - hemoglobin.
By Sarah Moudy Also known as Glucocerebrosidase deficiency.
PTEN (Cowden Syndrome) /.../ sld083.htm.
Role of the p21 Protein in the Fanconi Anemia (FA) Pathway
The Cell Cycle and Cancer. How do we define cancer? Cancer is: 1. a disease of the cell cycle. 2. a group of disorders that cause some of the body’s cells.
BLOOM HELICASE (and BLOOM SYNDROME)
Human Genetics: concepts and applications 6th edition Ricki Lewis Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Cancer. Cancer is a disease of the cell cycle Caused by one or more of the following: Increase in growth signals Loss of inhibitory signals In addition,
Copyright © by Holt, Rinehart and Winston. All rights reserved. ResourcesChapter menu CANCER how does it happen?
The cell cycle prokaryotic eukaryotic Control of the cell cycle loss of control- cancer What is cell differentiation and why does it happen? what is a.
Cancer as a genetic chapter 21 pp & lecture notes.
and its role in FA and other Cancers
The Genetic Basis of Cancer
HCDC4 functions as part of an E3 ligase in the ubiquitin-mediated degradation of proteins. Homologues: FBW7 (H. sapiens); Archipelago (D. melanogaster);
Targeting the DNA Damage Response in Cancer
CANCER.
Cancer.
breast cancer 2, early onsetpro What does this protein make up or do?
Regulation of the Cell Cycle & Cancer
Figure: Caption: The cell cycle is controlled at several checkpoints, including one at the G2/M transition, and another in late G1 phase before.
Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
FANCD2: Fanconi Anemia and Cancer
BRCA1 Breast Cancer.
Genomic Instability and Cancer
TSC1 in Facial Angiofibromas
The Role of Patch in Basal Cell Carcinoma
The Role of MSH2 in Hereditary Non-Polyposis Colon Cancer
Cancer- A Deeper Look (Part 4)
George-Lucian Moldovan, Alan D. D'Andrea  Cancer Cell 
Bloom Helicase & Bloom Syndrome
FANCF methylation contributes to chemoselectivity in ovarian cancer
A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2  Katharina Schlacher, Hong Wu, Maria Jasin 
Volume 46, Issue 2, Pages (April 2012)
BRCA1 cooperates in the Fanconi anemia/BRCA1 pathway.
Specific Tumor Suppressor Genes
TGF-β Pathway Inhibition Signals New Hope for Fanconi Anemia
FANCD2 Hurdles the DNA Interstrand Crosslink
Cooperation of the FA and BRCA1/2 proteins in a common ICL repair pathway. Cooperation of the FA and BRCA1/2 proteins in a common ICL repair pathway. Stalling.
Presentation transcript:

FANCD2 and Fanconi’s Anemia Brianna Eskola

Fanconi’s Anemia Autosomal recessive Affects 1/100,000 Bone marrow disease Loss of blood cells Seen before age 12 Symptoms Abnormal heart, lungs, and kidneys Bone problems Abnormal hands Pigment changes in skin Can lead to AML Squamous cell carcinomas http://www.radswiki.net

Fanconi's Anemia Cells Elevated apoptosis Prolonged G2 phase Chromosome instability with telomere shortening Sensitivity to DNA interstrand crosslinks bp1.blogger.com/.../s320/BreaksFanconi.gif

FANCD2 and the NCCFA Tumor Suppressor Highly conserved Primary role: recruit FANCD1/BRCA2 FA proteins; FANCA/B/C/E/F/G/L = nuclear core complex, NCCFA The NCCFA complex stabilizes replication forks theyorf.com/fanconi-anemia

DNA crosslink www.bioscience.org/2004/v9/af/1246/fig1.jpg

FANCD2 and FA protein pathway theyorf.com/fanconi-anemia

DNA repair

FANCD2 Pathways www.nature.com

Knockout Mice Fancd2 -/- Viable Sensitive to Mytomycin C Developmental delay More severe phenotype than other FA mutants High incidence of tumor development Do not develop Anemia Not due to ATM-dependent S-phase checkpoint

Rad51 and Brca2 normal in FANCD2 Mutants

The Big Picture

Testing Treatment Regular blood count checks Chromosome breakage test Growth factors Bone marrow transplant Anti-biotics Blood transfusions Chromosome breakage test Complete blood count test Bone marrow biopsy medical-genetics.net/Laboratory/Breakage.htm https://www.blueshieldca.com

Review FANCD2 serves two purposes: If FANCD2 mutated: Stalls the replication fork to recruit BRCA1 to repair interstrand crosslinks in DNA To arrest cell in S-phase If FANCD2 mutated: Hypersensitive to DNA crosslinks with high rate of apoptosis – anemia Avoid apoptosis creates clones with cytogenic defects– cancer especially AML

References http://www.nlm.nih.gov/medlineplus/ency/article/000334.htm - medicine plus http://www.fanconi.org/aboutfa/FA.htm - Fanconi Research Fund theyorf.blogspot.com/2007/10/fanconi-anaemia-... http://www.nature.com/nm/journal/v8/n6/full/nm0602-555.html - nature medicine Thompson, Larry H. et al. How Fanconi Anemia Proteins Promote the Four Rs: Replication, Recombination, Repair, and Recovery. 2005 Houghtaling, Scott. et al. Epithelial Cancer in Fanconi Anemia Complementation Group D2 Knockout Mice. 2003